Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Preiss, David; Giles, Thomas D; Thomas, Laine E; Sun, Jie-Lena; Haffner, Steven M; Holman, Rury R; Standl, Eberhard; Mazzone, Theodore; Rutten, Guy E; Tognoni, Gianni; Chiang, Fu-Tien; McMurray, John J V; Califf, Robert M

Preiss, David; Giles, Thomas D; Thomas, Laine E; Sun, Jie-Lena; Haffner, Steven M; Holman, Rury R; Standl, Eberhard; Mazzone, Theodore; Rutten, Guy E; Tognoni, Gianni; Chiang, Fu-Tien; McMurray, John J V; Califf, Robert M.

Affiliation

Preiss D; University of Glasgow, Glasgow, UK. david.preiss@glasgow.ac.uk

Stroke ; 44(9): 2590-3, 2013 Sep.

Article in En | MEDLINE | ID: mdl-23899915

Subject(s)

Cyclohexanes/therapeutic use; Glucose Intolerance/epidemiology; Phenylalanine/analogs & derivatives; Stroke/epidemiology; Tetrazoles/therapeutic use; Valine/analogs & derivatives; Aged; Antihypertensive Agents/therapeutic use; Comorbidity; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Female; Glucose Intolerance/drug therapy; Humans; Hypoglycemic Agents/therapeutic use; Male; Middle Aged; Nateglinide; Outcome Assessment, Health Care; Phenylalanine/therapeutic use; Predictive Value of Tests; Risk Factors; Stroke/etiology; Valine/therapeutic use; Valsartan

Key words

impaired glucose tolerance; stroke

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylalanine / Tetrazoles / Valine / Glucose Intolerance / Stroke / Cyclohexanes Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Stroke Year: 2013 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google